bf/NASDAQ:AXNX_icon.jpeg

NASDAQ:AXNX

Axonics, Inc.

  • Stock

70.98

USD last updated 14/08 01:46:41

Market Cap

3.45B

Beta: 0.39

PE Ratio

−278.47

PFCF: −3,945.94

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SN...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2.5-2-1.5-1-0.52017-12-312019-03-052021-02-252023-03-012024-08-01

    Revenue (Estimate*)

    20M40M60M80M100M120M140M2017-12-312019-03-052021-02-252023-03-012024-08-01

    *Estimate based on analyst consensus